LLX-424

N/A

Report date: 2025/04/22 20:00:06
NME

Base Information

Drug NameLLX-424
Drug Alias NameLLX-424
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycolate oxidase inhibitors
TargetsGlycolate oxidase
Therapy Area/IndicationsKidney Calculi
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLilac Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLilac Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsKidney Calculi
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A